![Tony Kingsley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tony Kingsley
President at
Annovation BioPharma, Inc.
Net worth: 435 842 $ as of 2026-05-30
Profile
Stuart Anthony Kingsley is President & Director at Annovation BioPharma, Inc. He is Independent Non-Executive Director at Indivior Pharmaceuticals, Inc. starting 2026 and at Indivior Ltd. starting 2025.
Former roles include President, Chief Executive Officer & Director at TARIS BioMedical LLC in 2019; President, Chief Executive Officer & Director at Scholar Rock, Inc. and Scholar Rock Holding Corp.
from 2020 to 2021; Chief Executive Officer & Director at Stablix, Inc. from 2022 to 2025; Director at Third Wave Technologies, Inc. in 2008; Independent Director at Proteon Therapeutics, Inc. from 2015 to 2019; Senior VP & GM-Gynecological Surgical Products at Hologic, Inc. in 2009; Head-Global Commercial Operations at Biogen, Inc. from 2011 to 2016; President-Diagnostic Products Division & Senior VP at Cytyc Corp.
in 2007; President & Chief Operating Officer at The Medicines Co. from 2016 to 2017; Partner at McKinsey & Co., Inc. until 2006.
Education includes undergraduate degree from Dartmouth College and MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.01% | 2026-05-12 | 12,100 ( 0.01% ) | 435 842 $ | 2026-05-30 |
Tony Kingsley active positions
| Companies | Position | Start |
|---|---|---|
Annovation BioPharma, Inc.
 Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products in the field of anesthesia, sedation and sleep | President | - |
Indivior Ltd.
 Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Director/Board Member | 2025-06-30 |
Former positions of Tony Kingsley
| Companies | Position | End |
|---|---|---|
Stablix, Inc.
 Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage biotechnology company, which pioneering small molecule medicines for targeted protein stabilization | Chief Executive Officer | 2025-08-31 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Chief Executive Officer | 2021-08-02 |
| SCHOLAR ROCK HOLDING CORPORATION | Chief Executive Officer | 2021-07-28 |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Chief Executive Officer | 2019-12-30 |
| PROTARA THERAPEUTICS, INC. | Director/Board Member | 2019-04-14 |
Training of Tony Kingsley
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
97
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Hologic, Inc.
 Hologic, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and supplies diagnostics devices, medical imaging systems & surgical products for women's | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Cytyc Corp.
 Cytyc Corp. Medical SpecialtiesHealth Technology Manufactures and markets medical diagnostic applications | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Third Wave Technologies, Inc.
 Third Wave Technologies, Inc. BiotechnologyHealth Technology Develops DNA and RNA detection technology | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Health Technology |
Annovation BioPharma, Inc.
Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products in the field of anesthesia, sedation and sleep | Health Technology |
Indivior Ltd.
Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage biotechnology company, which pioneering small molecule medicines for targeted protein stabilization | Commercial Services |
- Stock Market
- Insiders
- Tony Kingsley
